 |
 |
 |
|
The Safety and Pharmacokinetics of Fenofibrate in Patients With
Advanced Fibrosis, Including Those With Nonalcoholic Steatohepatitis
|
|
|
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Elijah Weber, Cara Nelson, Ann Qin, Ryan Huss, Marianne Camargo, Robert P. Myers, Shirley Li, Jie Zhang, Brian Kirby - Gilead Sciences, Inc., Foster City, California, USA




|
|
|
 |
 |
|
|